Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Comprehensive Loss

v3.20.1
Consolidated Statements of Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Income Statement [Abstract]    
REVENUES $ 735,000 $ 524,000
OPERATING EXPENSES    
Research and development 18,854,000 14,271,000
Sales, marketing and administration 12,040,000 11,546,000
TOTAL OPERATING EXPENSES 30,894,000 25,817,000
NET OPERATING LOSS (30,159,000) (25,293,000)
OTHER INCOME (EXPENSE)    
Interest and investment income 253,000 481,000
Other expense (21,000) (3,000)
TOTAL OTHER INCOME (EXPENSE) 232,000 478,000
LOSS BEFORE INCOME TAXES (29,927,000) (24,815,000)
Provision for income taxes (1,000) (1,000)
NET LOSS (29,928,000) (24,816,000)
Foreign currency translation adjustment, net of tax 16,000 (8,000)
COMPREHENSIVE LOSS $ (29,912,000) $ (24,824,000)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share) $ (1.02) $ (0.98)
Weighted average shares outstanding — basic and diluted (shares) 29,409,776 25,290,426